Australia's most trusted
source of pharma news
Thursday, 03 April 2025
Posted 1 April 2025 PM
An ongoing US congressional investigation into 2017 tax breaks has seen Pfizer accused of "what could be the largest tax-dodging scheme in the history of Big Pharma".
The allegation was made by US Democratic Senator Ron Wyden as he spearheads an investigation by the Senate Finance Committee into the industry's tax strategies.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.